Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;117(7):837-46.
doi: 10.1007/s00702-010-0424-5. Epub 2010 Jun 20.

The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease

Affiliations
Review

The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease

Mark Stacy. J Neural Transm (Vienna). 2010 Jul.

Abstract

Long-term treatment of Parkinson's disease (PD) with dopaminergic therapy is associated with a re-emergence of PD symptoms, referred to as wearing-off. Signs of wearing-off encompass motor symptoms, such as slowness of movement and stiffness, and non-motor symptoms, including anxiety and fatigue. Both motor and non-motor symptoms impact significantly on the function and quality of life of PD patients. Early detection and management of wearing-off has been shown to improve patient symptoms; however, identification of wearing-off, particularly the non-motor symptoms, is hampered by a lack of patient education, awareness, patient-physician communication, and limited time for evaluation. Several questionnaires have been developed to aid the detection of wearing-off. This review investigates the development and use of the Wearing-Off Questionnaires (WOQ-32, WOQ-19, and WOQ-9), as well as their sensitivity and specificity in identifying wearing-off. The manuscript also provides an overview of the motor and non-motor signs of wearing-off and highlights the available treatment strategies for managing this potentially debilitating phenomenon.

PubMed Disclaimer

References

    1. Ann Neurol. 2001 Mar;49(3):298-303 - PubMed
    1. Lancet. 2005 Mar 12-18;365(9463):947-54 - PubMed
    1. Arch Neurol. 2005 Feb;62(2):241-8 - PubMed
    1. Arch Neurol. 2000 Feb;57(2):263-7 - PubMed
    1. J Neural Transm (Vienna). 2007 Feb;114(2):211-7 - PubMed

MeSH terms

LinkOut - more resources